Leiomyomatosis and renal cell cancer, hereditary
Active Research Protocols
- 03-C-0066 – Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer
- 09-C-0072 – Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas with Botulinum Toxin
- 10-C-0114 – A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
- 89-C-0086 – Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014